09859nam 2200397 450 991058337680332120230120002710.00-08-101925-4(CKB)4100000000864060(EXLCZ)99410000000086406020180305d2018 uy 0engrdacontentrdamediardacarrierIron oxide nanoparticles for biomedical applications synthesis, functionalization and application /edited by Morteza Mahmoudi, Sophie LaurentAmsterdam Elsevier2018xvii, 315 p. ill. ;23 cmMetal oxides seriesIncludes bibliographical references and index.Machine generated contents note:1.Metal Oxide Particles and Their Prospects for Applications --1.1.Magnetic Metal Oxides /S. Laurent /S. Boutry /R.N. Muller --1.2.Metal Oxides With Photoluminescence Properties /S. Laurent /S. Boutry /R.N. Muller --1.3.Metal Oxides in Electronics, Catalysis, Gas Sensors and Energy Technologies /S. Laurent /S. Boutry /R.N. Muller --1.4.Metal Oxides in Biomedical Applications /S. Laurent /S. Boutry /R.N. Muller --References /S. Laurent /S. Boutry /R.N. Muller --Further Reading /S. Laurent /S. Boutry /R.N. Muller --2.Iron Oxide Nanoparticles for Biomedical Applications: Synthesis, Functionalization, and Application /S. Laurent /S. Boutry /R.N. Muller --2.1.Iron Nanoparticles: Advantages and Limitations for Biomedical Applications /G. Cotin /S. Piant /D. Mertz /D. Felder-Flesch /S. Begin-Colin --2.2.Synthesis of Iron Oxide Nanoparticles Aimed for Biomedical Applications /G. Cotin /S. Piant /D. Mertz /D. Felder-Flesch /S. Begin-Colin --2.3.Stabilization of the Nanosystems /G. Cotin /S. Piant /D. Mertz /D. Felder-Flesch /S. Begin-Colin --2.4.Methods of IONPs Functionalization for Biomedical Applications /G. Cotin /S. Piant /D. Mertz /D. Felder-Flesch /S. Begin-Colin --References /G. Cotin /S. Piant /D. Mertz /D. Felder-Flesch /S. Begin-Colin --3.Protein Corona: The Challenge at the Nanobiointerfaces /G. Cotin /S. Piant /D. Mertz /D. Felder-Flesch /S. Begin-Colin --3.1.Introduction /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /R. Spitler --3.2.The Protein Corona /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /R. Spitler --3.3."Hard" Versus "Soft" Corona /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /R. Spitler --3.4.Reversible Versus Irreversible Interactions Between NPs and Proteins /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /R. Spitler --References /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /R. Spitler --4.Nanocytotoxicity /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /R. Spitler --4.1.Introduction /S. Zanganeh /R. Spitler /M. Erfanzadeh /J.Q. Ho /M. Aieneravaie --4.2.Cytotoxicity /S. Zanganeh /R. Spitler /M. Erfanzadeh /J.Q. Ho /M. Aieneravaie --4.3.Superparamagnetic Iron Oxide Nanoparticles /S. Zanganeh /R. Spitler /M. Erfanzadeh /J.Q. Ho /M. Aieneravaie --References /S. Zanganeh /R. Spitler /M. Erfanzadeh /J.Q. Ho /M. Aieneravaie --5.Magnetic Particle Imaging (MPI) /S. Zanganeh /R. Spitler /M. Erfanzadeh /J.Q. Ho /M. Aieneravaie --5.1.Introduction /S. Zanganeh /M. Aieneravaie /M. Erfanzadeh /J.Q. Ho /R. Spitler --5.2.Superparamagnetic Iron Oxide Nanoparticles for MPI /S. Zanganeh /M. Aieneravaie /M. Erfanzadeh /J.Q. Ho /R. Spitler --5.3.Size and Homogeneity /S. Zanganeh /M. Aieneravaie /M. Erfanzadeh /J.Q. Ho /R. Spitler --5.4.Iron Oxide Nanoparticle Coatings /S. Zanganeh /M. Aieneravaie /M. Erfanzadeh /J.Q. Ho /R. Spitler --References /S. Zanganeh /M. Aieneravaie /M. Erfanzadeh /J.Q. Ho /R. Spitler --6.Targeted Iron Oxide (Nano)particles Used as MRI Contrast Agent in Small Animal Models /S. Zanganeh /M. Aieneravaie /M. Erfanzadeh /J.Q. Ho /R. Spitler --6.1.Introduction /S. Boutry /R.N. Muller /S. Laurent --6.2.MRI of Apoptosis With Iron Oxide-Based Compounds /R.N. Muller /S. Laurent /S. Boutry --6.3.MRI of Inflammatory Diseases With Iron Oxide-Based Compounds /S. Boutry /R.N. Muller /S. Laurent --6.4.MRI of Tumor Angiogenesis With Iron Oxide-Based Compounds /S. Boutry /R.N. Muller /S. Laurent --References /S. Boutry /R.N. Muller /S. Laurent --7.Dual-Modality Imaging /S. Boutry /R.N. Muller /S. Laurent --7.1.The Necessity of Dual Modality Imaging /A. Lahooti /S. Shanehsazzadeh /S. Laurent --7.2.Molecular Imaging /A. Lahooti /S. Shanehsazzadeh /S. Laurent --7.3.Multimodality Imaging /A. Lahooti /S. Shanehsazzadeh /S. Laurent --7.4.PET/MRI /A. Lahooti /S. Shanehsazzadeh /S. Laurent --7.5.Advantages /A. Lahooti /S. Shanehsazzadeh /S. Laurent --7.6.Challenges in PET/MRI /A. Lahooti /S. Shanehsazzadeh /S. Laurent --References /A. Lahooti /S. Shanehsazzadeh /S. Laurent --8.Current Outlook and Perspectives on Nanoparticle-Mediated Magnetic Hyperthermia /S. Laurent /S. Shanehsazzadeh /A. Lahooti --8.1.Historical Development and Outlook /C. Blanco-Andujar /F.J. Teran /D. Ortega --8.2.Rationalization of NP Characteristics for MH /C. Blanco-Andujar /F.J. Teran /D. Ortega --8.3.Interparticle Interactions /C. Blanco-Andujar /F.J. Teran /D. Ortega --8.4.Justification for the Use of Iron Oxides in Magnetic Hyperthermia /C. Blanco-Andujar /F.J. Teran /D. Ortega --8.5.Other Materials Used and Envisioned for Magnetic Hyperthermia /C. Blanco-Andujar /F.J. Teran /D. Ortega --8.6.Overview on the Current Instrumentation Available /C. Blanco-Andujar /F.J. Teran /D. Ortega --8.7.Clinical Trials (Past, Present, and Future Ones) /C. Blanco-Andujar /F.J. Teran /D. Ortega --8.8.Other Selected Topics in Magnetic Hyperthermia Research /C. Blanco-Andujar /F.J. Teran /D. Ortega --8.9.Conclusions and Prospects /C. Blanco-Andujar /F.J. Teran /D. Ortega --Acknowledgments /C. Blanco-Andujar /F.J. Teran /D. Ortega --References /C. Blanco-Andujar /F.J. Teran /D. Ortega --9.Drug Delivery /C. Blanco-Andujar /F.J. Teran /D. Ortega --9.1.Introduction /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --9.2.Iron Oxide Nanoparticles: Design Considerations /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --9.3.In Vivo Barriers /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler /S. Zanganeh /J.Q. Ho --9.4.Physicochemical Considerations /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --9.5.Hydrodynamic Size /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --9.6.Shape /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --9.7.Surface Properties /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --9.8.Directing Nanoparticles In Vivo /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --9.9.Drug Loading and Release /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --9.10.Toxicity /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --9.11.Coating of SPIONs /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --References /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --10.Tumor-Targeted Therapy /S. Zanganeh /J.Q. Ho /M. Aieneravaie /M. Erfanzadeh /M. Pauliah /R. Spitler --10.1.Introduction /M. Pauliah /S. Zanganeh /M. Erfanzadeh /J.Q. Ho --10.2.Nanotechnology and Cancer Therapy /M. Pauliah /S. Zanganeh /M. Erfanzadeh /J.Q. Ho --10.3.Iron Oxide Nanoparticles and Cancer Therapy /M. Pauliah /S. Zanganeh /M. Erfanzadeh /J.Q. Ho --10.4.Conclusion /M. Pauliah /S. Zanganeh /M. Erfanzadeh /J.Q. Ho --References /M. Pauliah /S. Zanganeh /M. Erfanzadeh /J.Q. Ho --11.Cancer Therapy /M. Pauliah /S. Zanganeh /M. Erfanzadeh /J.Q. Ho --11.1.Introduction /S. Zanganeh /J.Q. Ho /R. Spitler /T. Jafari /M. Erfanzadeh /M. Pauliah /N. Khakpash --11.2.The Role of Magnetic Iron Oxide in Cancer Therapy /S. Zanganeh /J.Q. Ho /R. Spitler /T. Jafari /N. Khakpash /M. Erfanzadeh /M. Pauliah --11.3.Diagnostic Imaging and Cancer Therapy /S. Zanganeh /J.Q. Ho /R. Spitler /T. Jafari /N. Khakpash /M. Erfanzadeh /M. Pauliah --11.4.Conclusion /S. Zanganeh /J.Q. Ho /R. Spitler /T. Jafari /N. Khakpash /M. Erfanzadeh /M. Pauliah --References /S. Zanganeh /J.Q. Ho /R. Spitler /T. Jafari /N. Khakpash /M. Erfanzadeh /M. Pauliah.Biomedical engineeringNanoparticlesMagnetic propertiesIron oxidesMagnetic propertiesBiomedical engineering.NanoparticlesMagnetic properties.Iron oxidesMagnetic properties.610.28Mahmoudi Morteza1979-911397Laurent Sophie1967-969270241008241008BOOK9910583376803321Iron oxide nanoparticles for biomedical applications2202448UNINA